glp 1 diverticulitis Are glucagon-like peptide‑1 (GLP‑1) receptor agonist injections contraindicated before colon resection for or irritable bowel syndrome? Can a patient with a

It has also been studied in individuals with type 2 diabetes, where it may help reduce post-meal glucose levels

The global market for weight-loss drugs is expected to reach $150 billion by 2035, according to research by Morgan Stanley, an increase from a previous forecast of $105 billion

doi: 10.3389/fphar.2025.1602976 Received 30 March 2025 Revised 13 November 2025 Accepted 14 November 2025 Published 19 December 2025 Volume 16 - 2025 Edited by Bernd Rosenkranz, Fundisa African Academy of Medicines Development, South Africa Reviewed by Kacper Nijakowski, Poznan University of Medical Sciences, Poland Miriam Njoki Karinja, Science for Africa Foundation, Kenya Updates Copyright 2025 Mazur, Ndokaj, Salerno, Vallone, Ardan, Bietolini, Carrouel, Wilk, Sarig, Ottolenghi and Bourgeois

Dosage gradually increases over the cycle

Healthons care model emphasizes patient-specific planning, safety monitoring, and informed decision-making to ensure combination therapy is used appropriately and effectively